Your browser doesn't support javascript.
loading
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis.
Le Gall, Aëlle; Hoang-Thi, Trieu-Nghi; Porcher, Raphaël; Dunogué, Bertrand; Berezné, Alice; Guillevin, Loïc; Le Guern, Véronique; Cohen, Pascal; Chaigne, Benjamin; London, Jonathan; Groh, Matthieu; Paule, Romain; Chassagnon, Guillaume; Vakalopoulou, Maria; Dinh-Xuan, Anh-Tuan; Revel, Marie Pierre; Mouthon, Luc; Régent, Alexis.
Afiliação
  • Le Gall A; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Hoang-Thi TN; Service de Radiologie, APHP-CUP, Hôpital Cochin, Paris, France.
  • Porcher R; Université de Paris, Paris, France.
  • Dunogué B; Service d'Epidémiologie Clinique, Hôpital Hôtel Dieu, AP-HP, Paris, France.
  • Berezné A; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Guillevin L; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Le Guern V; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Cohen P; Université de Paris, Paris, France.
  • Chaigne B; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • London J; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Groh M; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Paule R; Université de Paris, Paris, France.
  • Chassagnon G; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Vakalopoulou M; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Dinh-Xuan AT; Service de Médecine Interne, Centre de Référence Maladies Auto-Immunes et Systémiques Rares d'ile de France, APHP-CUP, Hôpital Cochin, Paris, France.
  • Revel MP; Service de Radiologie, APHP-CUP, Hôpital Cochin, Paris, France.
  • Mouthon L; Université de Paris, Paris, France.
  • Régent A; Centre de Vision Numérique, École Centrale Supelec, Gif-sur-Yvette, France.
Rheumatology (Oxford) ; 63(1): 103-110, 2024 Jan 04.
Article em En | MEDLINE | ID: mdl-37074923
ABSTRACT

OBJECTIVE:

Stratifying the risk of death in SSc-related interstitial lung disease (SSc-ILD) is a challenging issue. The extent of lung fibrosis on high-resolution CT (HRCT) is often assessed by a visual semiquantitative method that lacks reliability. We aimed to assess the potential prognostic value of a deep-learning-based algorithm enabling automated quantification of ILD on HRCT in patients with SSc.

METHODS:

We correlated the extent of ILD with the occurrence of death during follow-up, and evaluated the additional value of ILD extent in predicting death based on a prognostic model including well-known risk factors in SSc.

RESULTS:

We included 318 patients with SSc, among whom 196 had ILD; the median follow-up was 94 months (interquartile range 73-111). The mortality rate was 1.6% at 2 years and 26.3% at 10 years. For each 1% increase in the baseline ILD extent (up to 30% of the lung), the risk of death at 10 years was increased by 4% (hazard ratio 1.04, 95% CI 1.01, 1.07, P = 0.004). We constructed a risk prediction model that showed good discrimination for 10-year mortality (c index 0.789). Adding the automated quantification of ILD significantly improved the model for 10-year survival prediction (P = 0.007). Its discrimination was only marginally improved, but it improved prediction of 2-year mortality (difference in time-dependent area under the curve 0.043, 95% CI 0.002, 0.084, P = 0.040).

CONCLUSION:

The deep-learning-based, computer-aided quantification of ILD extent on HRCT provides an effective tool for risk stratification in SSc. It might help identify patients at short-term risk of death.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França